Characteristic | Data |
Age (y) | |
Median | 62 |
Range | 50–92 |
GS (n) | |
3 + 3 = 6 | 70 (9.9%) |
3 + 4 = 7 | 122 (17.4%) |
4 + 3 = 7 | 116 (16.5%) |
3 + 5 = 8 | 12 (2%) |
4 + 4 = 8 | 117 (16.7%) |
5 + 3 = 8 | 4 (0.5%) |
4 + 5 = 9 | 128 (18.3%) |
5 + 4 = 9 | 36 (5.1%) |
5 + 5 = 10 | 14 (1.9%) |
Unknown | 82 (11.7%) |
PSA at time of scan (ng/mL) | |
Median | 9.3 |
Range | 0.003–4,337 |
PET/CT indication (n) | |
Staging | 249 |
Restaging | 376 |
Therapy response | 76 |
Symptom-positive patients (n) | 55 |
Symptom-negative patients (n) | 546 |